Product Program year 2025 Source: CMS Open Payments

Miniendo II

Device Orthodontics

PDI 00889989078114

Open in the dashboard

General payments

$18,683

574 payments

Research payments

$0

0 payments

Through program year 2025, $18,683 in general payments and $0 in research payments were reported against Miniendo II (Orthodontics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $3,487 127
2024 General $2,821 90
2023 General $3,102 93
2022 General $4,264 130
2021 General $5,010 134

Breakdown

Who paid General payments · program years 2021–2025
  1. Ormco Corporation $12,088 351 payments
  2. Envista Holdings Corporation $6,307 217 payments
  3. Kerr Corporation $288 6 payments
Top recipients General payments · program year 2025
  1. Brooke Skolnick Dentist · Roseland, NJ $144 4% · 1 payment
  2. Lawrence Moranda Dentist, Orthodontics and Dentofacial Orthopedics · Palm Desert, CA $141 4% · 1 payment
  3. Kelly Klontz Dentist, Orthodontics and Dentofacial Orthopedics · Oklahoma City, OK $131 4% · 1 payment
  4. Kevin Bibona Dentist, Orthodontics and Dentofacial Orthopedics · Richmond, VA $103 3% · 3 payments
  5. Garrett Weston Dentist, Orthodontics and Dentofacial Orthopedics · Larchmont, NY $94 3% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dentist, Orthodontics and Dentofacial Orthopedics Dentist $2,489 72% · 76 practitioners
  2. Dentist $584 17% · 19 practitioners
  3. Dentist, General Practice Dentist $351 10% · 15 practitioners
  4. Dentist, Oral and Maxillofacial Pathology Dentist $16 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Illinois $464 13% · 17 recipients
  2. California $323 9% · 8 recipients
  3. New York $305 9% · 9 recipients
  4. New Jersey $298 9% · 5 recipients
  5. Pennsylvania $252 7% · 8 recipients

The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

574 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record